Esketamine
IRB-20230021-R
Approved small_molecule active
Quick answer
Esketamine for Postpartum Depression is a Approved program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The First People's Hospital of Lianyungang
- Indication
- Postpartum Depression
- Phase
- Approved
- Modality
- small_molecule
- Status
- active